Day One Biopharmaceuticals I share price logo

Day One Biopharmaceuticals I

NASDAQ: DAWN

$21.53

+0.04

(+0.19%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 22 Apr 2026

Day One Biopharmaceuticals I Stock Performance

as on April 23, 2026 at 2:54 pm IST

  • Day's Low

    Day's High

    $21.49
    $21.51
    downward going graph

    0.19%

    Downside

    -0.09%

    Upside

    downward going graph

  • 52 Week's Low

    $5.64
    $21.53
    downward going graph

    73.83%

    Downside

Day One Biopharmaceuticals I share price movements today

Previous Close
$21.49
Open
$21.49
Volume
1.4M
Day's Low - High
$21.49 - $21.51
52 Week Low - High
$5.64 - $21.53

Day One Biopharmaceuticals I Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Day One Biopharmaceuticals I Stock Fundamentals & Key Indicators

Check Day One Biopharmaceuticals I market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Day One Biopharmaceuticals I vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Day One Biopharmaceuticals I with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Day One Biopharmaceuticals I image
Day One Biopharmaceuticals I
BUY$-NANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$38.0B115.2%71.3912.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.4B106.5%25.8435.51%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$32.7BNA71.448.94%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$74.7B40.03%17.3929.65%

Analyst Recommendation on Day One Biopharmaceuticals I Stock

Based on 17 analysts

BUY

82.35%

Buy

11.76%

Hold

5.88%

Sell

Based on 17 analysts, 82.35% of analysts recommend a 'BUY' rating for Day One Biopharmaceuticals I. Average target price of $21.5

Day One Biopharmaceuticals I Share Price Target

Get share price movements and forecasts by analysts on Day One Biopharmaceuticals I.

What analysts predicted

-0.14%DOWNSIDE

Target Price

$21.5

Current Price

$21.53

Analyzed by

17 Analysts

Target

$21.50

Day One Biopharmaceuticals I target price $21.5, a slight downside of -0.14% compared to current price of $21.53. According to 17 analysts rating.

Day One Biopharmaceuticals I Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
8
93
29
30
33
39
53
Gross Profit
0
0
0
7
92
26
27
30
35
47
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-46
-54
-62
-4
37
-65
-35
-30
-19
-21
Net Profit Margin
0.00%
-9734.11%
0.00%
-53.80%
39.50%
-224.99%
-117.02%
-89.42%
-49.57%
-39.61%

Day One Biopharmaceuticals I Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
131
158
Gross Profit
-
0
0
0
0
125
140
Operating Income
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-12
-40
-70
-132
-188
-95
-107
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-72.81%
-67.85%

Global Institutional Holdings in Day One Biopharmaceuticals I

Funds
Holdings
Deerfield Management Co
3.6%
Pictet Asset Manangement SA
2.9%
Alyeska Investment Group, L.P.
2.94%
Hudson Bay Capital Management LP
1.65%
Vanguard Group Inc
6.08%
See all

Day One Biopharmaceuticals I News & Key Events

  • img

    Today's Timeline - 11 January

    Mon, 03:30 AM

    -

    Day One announces preliminary 2025 net product revenue and provides 2026 guidance of $225-$250 million for Ojemda.

Insights on Day One Biopharmaceuticals I

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DAWN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, DAWN stock has moved up by 80.2%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DAWN has outperformed top 5 stocks with highest market-cap in its industry

About Day One Biopharmaceuticals I

Day One Biopharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing targeted therapies for people of all ages with life-threatening diseases. It partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. Its commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor. OJEMDA is used for the treatment of patients over six months of age and older with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation. Its pipeline product candidates include DAY301 and Emi-Le (emiltatug ledadotin). DAY301 is a novel Antibody Drug Conjugate, or ADC, targeting protein-tyrosine kinase 7, or PTK7. Emi-Le (emiltatug ledadotin) is a novel antibody drug conjugate (ADC) targeting the B7-H4 protein in clinical development to treat the rare cancer adenoid cystic carcinoma (ACC).
OrganisationDay One Biopharmaceuticals I
E-voting on sharesClick here to vote

FAQs

What is Day One Biopharmaceuticals I share price today?

Day One Biopharmaceuticals I share price today is $21.53 as on at the close of the market. Day One Biopharmaceuticals I share today touched a day high of $21.51 and a low of $21.49.

What is the 52 week high and 52 week low for Day One Biopharmaceuticals I share?

Day One Biopharmaceuticals I share touched a 52 week high of $21.53 on and a 52 week low of $5.64 on . Day One Biopharmaceuticals I stock price today i.e. is closed at $21.53,which is 0.00% down from its 52 week high and 282.08% up from its 52 week low.

How to invest in Day One Biopharmaceuticals I Stock (DAWN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Day One Biopharmaceuticals I on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Day One Biopharmaceuticals I Shares that will get you 0.0697 shares as per Day One Biopharmaceuticals I share price of $21.53 per share as on April 23, 2026 at 9:24 am IST.

What is the minimum amount required to buy Day One Biopharmaceuticals I Stock (DAWN) from India?

Indian investors can start investing in Day One Biopharmaceuticals I (DAWN) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Day One Biopharmaceuticals I stock (as per the Rupee-Dollar exchange rate as on ). Based on Day One Biopharmaceuticals I share’s latest price of $21.53 as on April 23, 2026 at 9:24 am IST, you will get 0.4645 shares of Day One Biopharmaceuticals I. Learn more about fractional shares .